JHJay Harvey

Jay Harvey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jay Harvey has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Frequency Band Personalization for Seizure Network Analysis in Multifocal Patients

    by Genchang Peng, Mehrdad Nourani, Omar Nofal, Jay Harvey

    Stereo-electroencephalography (SEEG) is commonly used for pre-surgical evaluation in patients with multifocal epilepsy undergoing responsive neurostimulation (RNS). Seizure network modeling, a data-driven approach to assist RNS implantation and adjustment, benefits from individualized ictal signatures learned from SEEG data, including repetitive sharp waves, rhythmic discharges, and prominent frequency bands in seizure activities. This is all in pursuit of the earliest possible detection so that the RNS therapy can be delivered as soon as a potential seizure is on the horizon. To improve individualized treatment, this paper proposes a data-driven methodology for personalizing frequency-band selection using a SEEG-based seizure network in patients with multifocal epilepsy. A directed seizure network is first proposed using SEEG data, where network nodes are selected SEEG points, and spectral edges are characterized by a directed transfer function. To further enhance the robustness of network modeling, surrogate data analysis is applied to ensure the significance of network estimation. Then, the density differences between the seizure onset zone and remaining regions are extracted using subgraph density as a heuristic to select the discriminative frequency range with the highest difference as the optimal band. The selection result is further validated using a machine learning classifier for seizure detection. Across ten multifocal patients, our personalized selection achieved an Area-Under score of 0.94 out of 1 in the seizure classification task, outperforming standard bands in distinguishing ictal from pre-ictal states, and exhibiting type-specific spectral patterns with consistency through different frequency-domain network metrics.


  • Open Access

    SEEG-Based Bilateral Seizure Network Analysis for Neurostimulation Treatment

    by Genchang Peng, Mehrdad Nourani, Jay Harvey

    Objective: Epilepsy patients with drug-resistant seizures emanating from two or more distinct regions of left and right hemispheres are the primary candidates for neurostimulation treatment. Stereo-electroencephalography (SEEG) is a minimally invasive technique to monitor and evaluate brain activities during seizures before stimulator implantation. Methods: This work proposes a seizure network modeling method using SEEG to analyze the functional connectivity of epileptogenic zone during bilateral seizures. Network nodes are selected subset of SEEG contact points, and network edges are directed signal correlations calculated from directed transfer function. Based on signal directionality, four connectivity values are extracted to measure the intra- and inter-activities that are within or between the left and right hemispheres, respectively. Statistical difference between connectivity values is used to quantify the seizure impact of each hemisphere. A subset of network nodes is selected from impactful side as stimulation target candidates. Results: Experimental results are validated on ten patients having different seizure types with bilateral onset. Each seizure type has specific connectivity patterns that show different importance from each brain side. Selection of neurostimulation targets from primary side are consistent with clinicians’ decision. Relationships are found among connectivity differences, seizure types and stimulation outcomes. Conclusion: Using SEEG signals, we can capture specific connectivity differences associated with bilateral seizure networks. Such differences are related with corresponding neurostimulation targets and stimulating outcomes. Significance: The proposed work elucidates the difference of network connectivity for bilateral patients, and assists clinicians to choose the stimulation targets and to predict the potential outcomes.


  • Open Access

    An Unobtrusive and Lightweight Ear-worn System for Continuous Epileptic Seizure Detection

    by Abdul Aziz, Nhat Pham, Neel Vora, Cody Reynolds, Jaime Lehnen, Pooja Venkatesh, Zhuoran Yao, Jay Harvey, Tam Vu, Kan Ding, et al.

    Epilepsy is one of the most common neurological diseases globally (around 50M people globally). Fortunately, up to 70% of people with epilepsy could live seizure-free if properly diagnosed and treated, and a reliable technique to monitor the onset of seizures could improve the quality of life of patients who are constantly facing the fear of random seizure attacks. The current gold standard, video-EEG (v-EEG), involves attaching over 20 electrodes to the scalp, is costly, requires hospitalization, trained professionals, and is uncomfortable for patients. To address this gap, we developed EarSD , a lightweight and unobtrusive ear-worn system to detect seizure onsets by measuring physiological signals behind the ears. This system can be integrated into earphones, headphones, or hearing aids, providing a convenient solution for continuous monitoring. EarSD is an integrated custom-built sensing - computing - communication ear-worn platform to capture seizure signals, remove the noises caused by motion artifacts and environmental impacts, and stream the collected data wirelessly to the computer/mobile phone nearby. EarSD ’s ML algorithm, running on a server, identifies seizure-associated signatures and detects onset events. We evaluated the proposed system in both in-lab and in-hospital experiments at the University of Texas Southwestern Medical Center with epileptic seizure patients, confirming its usability and practicality.


  • Open Access

    Stereo-electroencephalographic seizure localization in patients with mesial temporal sclerosis: A single center experience

    by Bill Zhang, Irina Podkorytova, Ryan Hays, Ghazala Perven, Mark Agostini, Jay Harvey, Rodrigo Zepeda, Sasha Alick-Lindstrom, Marisara Dieppa, Alex Doyle, et al.


  • Open Access

    Earables as Medical Devices: Opportunities and Challenges

    by Abdul Aziz, Ravi Karkar, Kan Ding, Jay Harvey, Phuc Nguyen


  • Provider and Patient Opinions on Real-Time Seizure Detection via Over-the-Ear Device (P10-1.005)

    by Pooja Venkatesh, Zhuoran Yao, Jamie Lehnen, Kan Ding, Vp Nguyen, Jay Harvey

    Objective: To examine epileptologist opinions and patient experiences regarding an over-the-ear real-time seizure detection device. Background: Our team developed BrainSD, a behind-the-ear seizure monitor that detects EEGs with four scalp contacts. BrainSD maximizes detection accuracy and usability for clinicians, and comfort and ease-of-use for patients. It was tested on 33 patients admitted to the Epilepsy Monitoring Unit (EMU) at a Level 4 Epilepsy Center. BrainSD was worn for 42 hours on average and recorded 14 seizure events. Design/Methods: An anonymous 14-question survey was offered to study participants at the end of the study. Subsequently, nine epileptologists were invited to a one-hour focus group to obtain opinions regarding portable seizure detection devices. Results: Thirty (91%) of thirty-three participants who wore BrainSD completed the post-survey. Of the thirty, seven (23.3%) strongly agreed and fifteen (50%) agreed that BrainSD was comfortable. Discomfort was expressed (16.7%) due to pressure, and the adhesive glue. Twelve (40%) strongly agreed and fourteen (46.7%) agreed that BrainSD was easy to use. Twelve (40%) patients said they would wear BrainSD continuously for over a week. Eight (26.7%) strongly agreed and ten (33.3%) agreed that BrainSD is socially acceptable to wear in public. Nine (30%) strongly agreed and ten (33.3%) agreed that they slept well while wearing BrainSD. For potential BrainSD improvements, three (10%) inquired about an auxiliary mobile application and six (20%) about seizure prediction and alerting. Providers expressed interest in a device that detects non-motor focal seizures; uploads recordings in real-time for viewing; alerts patients before an epileptic event; and allows patients to log their events. Hesitancies with over-the-ear devices included the risk of false positive rates with the implemented 2-channel EEG. Conclusions: BrainSD has the features that users desire, is acceptable and comfortable for patients, and meets epileptologists’ expectations. More features will be considered to optimize BrainSD in the future. Disclosure: Miss Venkatesh has nothing to disclose. Mr. Yao has nothing to disclose. Ms. Lehnen has nothing to disclose. The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS. Dr. Nguyen has nothing to disclose. Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals.

  • Emergency department visits and readmissions in patients with psychogenic nonepileptic seizures (PNES) at a safety net hospital

    by Swetha Ramamurthy, L. Steven Brown, Mark Agostini, Sasha Alick Lindstorm, Hina Dave, Marisara Dieppa, Kan Ding, Alexander Doyle, Ryan Hays, Jay Harvey, et al.


  • Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes

    by Rodrigo Zepeda, Yoona Lee, Mark Agostini, Sasha Alick Lindstrom, Hina Dave, Marisara Dieppa, Kan Ding, Alexander Doyle, Jay Harvey, Ryan Hays, et al.

    Due to the coronavirus disease 2019 (COVID-19) pandemic, the state of Texas-limited elective procedures to conserve beds and personal protective equipment (PPE); therefore, between March 22 and May 18, 2020, admission to the epilepsy monitoring unit (EMU) was limited only to urgent and emergent cases. We evaluated clinical characteristics and outcomes of these patients who were admitted to the EMU. Nineteen patients were admitted (one patient twice) with average age of 36.26 years (11 female) and average length of stay 3 days (range: 2–9 days). At least one event was captured on continuous EEG (cEEG) and video monitoring in all 20 admissions (atypical in one). One patient had both epileptic (ES) and psychogenic non-epileptic seizures (PNES) while 10 had PNES and 9 had ES. In 8 of 9 patients with ES, medications were changed, while in 5 patients with PNES, anti-epileptic drugs (AED) were stopped; the remaining 5 were not on medications. Of the 14 patients who had seen an epileptologist pre-admission, 13 (or 93%) had their diagnosis confirmed by EMU stay; a statistically significant finding. While typically an elective admission, in the setting of the COVID-19 pandemic, urgent and emergent EMU admissions were required for increased seizure or event frequency. In the vast majority of patients (13 of 19), admission lead to medication changes to either better control seizures or to change therapeutics as appropriate when PNES was identified.


  • Open Access

    Non-lesional mesial temporal lobe epilepsy requires bilateral invasive evaluation

    by Ghazala Perven, Irina Podkorytova, Kan Ding, Mark Agostini, Sasha Alick, Rohit Das, Hina Dave, Marisara Dieppa, Alexander Doyle, Jay Harvey, et al.